SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-011355
Filing Date
2021-05-07
Accepted
2021-05-07 16:45:33
Documents
47
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q dffn20210331_10q.htm 10-Q 419510
2 EXHIBIT 31.1 ex_247718.htm EX-31.1 9057
3 EXHIBIT 31.2 ex_247719.htm EX-31.2 8931
4 EXHIBIT 32.1 ex_247720.htm EX-32.1 4757
5 EXHIBIT 32.2 ex_247721.htm EX-32.2 4749
12 logo02.gif GRAPHIC 4839
  Complete submission text file 0001437749-21-011355.txt   2339026

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT dffn-20210331.xml EX-101.INS 332616
7 XBRL TAXONOMY EXTENSION SCHEMA dffn-20210331.xsd EX-101.SCH 32015
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dffn-20210331_cal.xml EX-101.CAL 23105
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dffn-20210331_def.xml EX-101.DEF 192652
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE dffn-20210331_lab.xml EX-101.LAB 195579
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dffn-20210331_pre.xml EX-101.PRE 211906
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37942 | Film No.: 21903556
SIC: 2834 Pharmaceutical Preparations